Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.

Proceedings of the National Academy of Sciences of the United States of America - 6 Jul 2010

Dhar Neeraj, McKinney John D

Abstract excerpt

Tuberculosis (TB) is notoriously difficult to cure, requiring administration of multiple antibiotics for 6 mo or longer. Conventional anti-TB drugs inhibit biosynthetic processes involved in cell growth and division, such as DNA replication, RNA transcription, protein translation, and cell wall b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to ATP-Binding Cassette Transporters
Share to GTP-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoniazid

Share to Macrophages

Share to Mycobacterium tuberculosis

Share to Nitric Oxide Synthase Type II

Share to Tuberculosis

Source

Open in PubMed Open full text

Identifiers

PMID: 20566858
DOI: 10.1073/pnas.1003219107
PMCID: PMC2901468

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20566858-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.PMID 20566858Read ↗

Identification of novel loci associated with mycobacterial isoniazid resistance.Semantic proximity Read ↗

Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.Semantic proximity Read ↗

The mechanism of isoniazid killing: clarity through the scope of genetics.Semantic proximity Read ↗

Targeting Phenotypically Tolerant Mycobacterium tuberculosisSemantic proximity Read ↗

Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

KatG inactivation generates vulnerabilities in isoniazid resistant strains of <i>Mycobacterium tuberculosis</i>Semantic proximity Read ↗

Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of miceSemantic proximity Read ↗

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosisSemantic proximity Read ↗

Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal studySemantic proximity Read ↗

Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistanceSemantic proximity Read ↗

Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo.Semantic proximity Read ↗

Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.